GO

Stellus Capital Investment CorpFRA Stellus Capital Stock Report

Last reporting period 30 Sep, 2024

Updated 21 Nov, 2024

Last price

Market cap $B

0.354

Micro

Exchange

XFRA - Deutsche Boerse AG

GO0.F Stock Analysis

GO

Neutral

Based on Eyestock quantitative analysis, GO0.F`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

54/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

53.3 %

Greatly undervalued

Market cap $B

0.354

Dividend yield

11.30 %

Shares outstanding

19.701 B

Stellus Capital Investment Corp., a traded business development company invests in companies located in the United States with an EBITDA of $5 to $50 million. The company is headquartered in Houston, Texas and currently employs 0 full-time employees. The company went IPO on 2012-08-11. The firm originates and invests primarily in private middle-market through first lien, (including unitranche), second lien, and unsecured debt financing, and corresponding equity co-investments. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. The firm invests in various industry sectors, including business services, energy, general industrial, government services, healthcare, software, and specialty finance. Its services sectors include healthcare and pharmaceuticals, aerospace and defense, and beverage, food, and tobacco; media includes broadcasting and subscription and advertising, printing and publishing, and consumer goods include durables. The Company’s investment advisor is Stellus Capital Management, LLC.

View Section: Eyestock Rating